Control of growth in neuroendocrine gastro-enteropancreatic tumours

被引：6

作者：

Arnold, R

Frank, M

机构：

[1] Department of Internal Medicine, Philipps University, Marburg

来源：

DIGESTION | 1996年 / 57卷

关键词：

gastro-enteropancreatic tumours; octreotide; interferons; chemotherapy;

D O I：

10.1159/000201400

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

This paper reviews data on the effect of pharmacological anti-tumour agents on tumour growth in patients with malignant gastro-enteropancreatic (GEP) tumours. Agents include long-acting somatostatin analogues, interferon-alpha, a combination of both, chemotherapy, and chemo-embolisation. Characteristics of tumours are considered which should be taken into account in the management of patients with metastatic endocrine GEP tumours, including growth rate. Tumour type should be matched to the anti-proliferative strategy.

引用

页码：69 / 71

页数：3

共 21 条

[11]

KRAENZLIN ME, 1983, LANCET, V2, P1501

[12] SOMATOSTATIN ANALOGS INHIBIT GROWTH OF PANCREATIC-CANCER BY STIMULATING TYROSINE PHOSPHATASE [J].